'Cd4 cell count' diaporamas de présentation

Cd4 cell count - PowerPoint PPT Presentation


a −10% non-inferiority margin for individual studies.

a −10% non-inferiority margin for individual studies.

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT – NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RESULTS FROM THE GEMINI STUDIES.

By albert
(383 views)

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

Thinking of Now and Tomorrow: Emerging Treatment Paradigms. Pedro Cahn. Disclosures. Advisory boards : Merck, ViiV Healthcare Research funds : Abbvie , Merck, Richmond, ViiV Healthcare Speaker at educational activities : Abbvie , Gilead, Merck, ViiV Healthcare.

By tyrell
(180 views)

Poster # 873 *Sharon Nachman SUNY Stony Brook Stony Brook, NY sharon.nachman@stonybrook

Poster # 873 *Sharon Nachman SUNY Stony Brook Stony Brook, NY sharon.nachman@stonybrook

CROI 2010 San Francisco, CA. . . Pharmacokinetic (PK), Safety and Efficacy Data on Cohort IIA; youth aged 6-11 from IMPAACT P1066: A Phase I/II Study to Evaluate Raltegravir (RAL) in HIV-1 Infected Youth . Poster # 873 *Sharon Nachman SUNY Stony Brook Stony Brook, NY

By jill
(199 views)

Background

Background

Background

By kaiser
(45 views)

in + care Campaign Meet the Author December 12, 2012

in + care Campaign Meet the Author December 12, 2012

in + care Campaign Meet the Author December 12, 2012. Ground Rules for Webinar Participation. Actively participate and write your questions into the chat area during the presentation(s) Do not put us on hold Mute your line if you are not speaking (press *6, to unmute your line press #6)

By fox
(158 views)

Introductory talk

Introductory talk

Introductory talk. D Costagliola. Chapter 1. The current debate on abacavir. All or majority of patients antiretroviral-experienced at ABC initiation. All or majority of patients antiretroviral naive at ABC inclusion.

By belden
(118 views)

Introductory talk

Introductory talk

Introductory talk. D Costagliola. Chapter 1. THE CURRENT DEBATE ON ABACAVIR. All or majority of patients antiretroviral-experienced at ABC initiation. All or majority of patients antiretroviral naive at ABC inclusion.

By zeki
(118 views)

HIV Testing and Counseling and Male Circumcision Experiences from Zimbabwe

HIV Testing and Counseling and Male Circumcision Experiences from Zimbabwe

Scaling-up male circumcision programmes in the Eastern and Southern Africa Region Country update meeting. HIV Testing and Counseling and Male Circumcision Experiences from Zimbabwe. Karin Hatzold, MD, MPH Director HIV Services PSI Zimbabwe. Issues HTC/MC.

By cayla
(179 views)

Initiation of antiretroviral treatment

Initiation of antiretroviral treatment

Initiation of antiretroviral treatment. Dr. José R Arribas Prof. Christine Katlama. Viral suppression > 90% Immune restoration Better ARV drugs Simplified treatment Increased survival Transmission reduced. HIV : a success story of research. Pathogenesis New paradigm.

By landry
(127 views)

Abstract

Abstract

WePeB5707. Prevalence of resistance mutations in a cohort of treatment-naïve people with chronic HIV infection in the U.S.: CPCRA 058

By stu
(59 views)

Safe Motherhood Programme

Safe Motherhood Programme

Safe Motherhood Programme. Public Health Annual Performance Review 2006. Goal. The goal of the Safe Motherhood Programme is to improve women’s health in general and especially, to reduce maternal morbidity and mortality and to contribute to reducing infant morbidity and mortality.

By kerryn
(324 views)

Bienvenida

Bienvenida

Bienvenida. Bienvenue. Welkom. Welcome. RETROVIRUS RESEARCH CENTER. CLINICAL, SOCIODEMOGRAPHIC AND IMMUNOLOGICAL PROFILE: BEFORE, DURING AND AFTER THE IMPLEMENTATION OF HAART THERAPY.

By holt
(182 views)

Initiation of antiretroviral treatment

Initiation of antiretroviral treatment

Initiation of antiretroviral treatment. Dr. José R Arribas Prof. Christine Katlama. Viral suppression > 90% Immune restoration Better ARV drugs Simplified treatment Increased survival Transmission reduced. HIV : a success story of research. Pathogenesis New paradigm.

By blaze
(186 views)

Comparison of NRTI combinations

Comparison of NRTI combinations

Comparison of NRTI combinations. ZDV/3TC vs TDF + FTC Study 934 ABC/3TC vs TDF/FTC HEAT Study ACTG A5202 Study ASSERT Study TAF vs TDF Study 292-0102. Study 934: zidovudine/lamivudine fixed dose combination vs tenofovir + emtricitabine. Study 934. Design. Randomisation* 1 : 1

By kylar
(246 views)

Initiation of antiretroviral treatment

Initiation of antiretroviral treatment

Initiation of antiretroviral treatment. Dr. José R Arribas Prof. Christine Katlama. Viral suppression > 90% Immune restoration Better ARV drugs Simplified treatment Increased survival Transmission reduced. HIV : a success story of research. Pathogenesis New paradigm.

By enan
(128 views)

HCT Campaign and ARV Expansion programme

HCT Campaign and ARV Expansion programme

HCT Campaign and ARV Expansion programme. Business sectors leaders 29 March 2010. Goals. Implement the new treatment guidelines and Presidential mandates Train health workers on the new guidelines and policies Implement the HCT campaign strategy

By may
(110 views)

WEPDB0101

WEPDB0101

DIONE – 24 week efficacy, safety, tolerability and pharmacokinetics of DRV/r QD in treatment-naïve adolescents, 12 to <18 years.

By ursa
(128 views)

Selected and summarized by Douglas J. Ward, MD Dupont Circle Physicians Group Washington, DC

Selected and summarized by Douglas J. Ward, MD Dupont Circle Physicians Group Washington, DC

Highlights of the 43rd Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC) September 14-17, 2003; Chicago, Illinois. Selected and summarized by Douglas J. Ward, MD Dupont Circle Physicians Group Washington, DC. Supported by an unrestricted educational grant from.

By nodin
(120 views)

HIV-Associated Opportunistic Infections 2009

HIV-Associated Opportunistic Infections 2009

HIV-Associated Opportunistic Infections 2009. Robert D. Harrington, M.D. University of Washington. MMWR 1981. CD4 Count and Opportunistic Infections. CD4 Cell Count. Bacterial Pneumonia, TB, HSV, Cryptosporidiosis. 1,000. Thrush, lymphoma, KS. 500. 200. PCP. 100.

By lacy
(341 views)

OVERVIEW OF HIV VIROLOGY

OVERVIEW OF HIV VIROLOGY

OVERVIEW OF HIV VIROLOGY. BY EKEZIE F.M.C. INTRODUCTION AND VIROLOGY OF HIV. Hx: 1978 Unusual diseases among gays in USA 1980 31 deaths in USA 1981 PCP and Oropharyngeal candidiasis in 5 young homosexuals 1982 Dx linked to blood. AIDS first used in July 27

By harding-conway
(648 views)

View Cd4 cell count PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Cd4 cell count PowerPoint presentations. You can view or download Cd4 cell count presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.